Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
CD137L-DC-EBV-VAX 树突状细胞疗法治疗局部复发或转移性鼻咽癌是安全的,并具有临床益处
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-021-03075-3
Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon